Abstract
Rasmussen syndrome (RS) is a clinical diagnosis characterized by persistent focal seizures in a previously healthy child. Occasionally, the typical features of RS may be followed by another diagnosis. We discuss the course of a 12-year-old girl who presented with RS but was later diagnosed with CNS granulomatous disease and NOD2/CARD15 mutations. Her response to infliximab suggests that it should be included in immune-modulatory therapies used to treat these refractory disorders.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 640-643 |
| Number of pages | 4 |
| Journal | Neurology |
| Volume | 69 |
| Issue number | 7 |
| DOIs | |
| State | Published - Aug 1 2007 |
| Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology
Fingerprint Dive into the research topics of 'Rasmussen syndrome and CNS granulomatous disease with NOD2/CARD15 mutations'. Together they form a unique fingerprint.
Cite this
Goyal, M., Cohen, M. L., Bangert, B. A., Robinson, S., & Singer, N. G. (2007). Rasmussen syndrome and CNS granulomatous disease with NOD2/CARD15 mutations. Neurology, 69(7), 640-643. https://doi.org/10.1212/01.wnl.0000267429.89675.03